H.Res. 699

119 HRES 699 IH: Expressing support for the designation of September 2025 as “National Polycystic Kidney Disease Awareness Month”, and raising awareness and understanding of polycystic kidney disease.
 U.S. House of Representatives
 2025-09-11
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 IV  119th CONGRESS  1st Session  H. RES. 699  IN THE HOUSE OF REPRESENTATIVES   September 11, 2025   Mr. Cleaver  (for himself and  Mr. Graves ) submitted the following resolution; which was referred to the  Committee on Energy and Commerce    RESOLUTION
Expressing support for the designation of September 2025 as  National Polycystic Kidney Disease Awareness Month , and raising awareness and understanding of polycystic kidney disease.
Whereas designating September 2025 as  National Polycystic Kidney Disease Awareness Month  will raise public awareness and understanding of polycystic kidney disease, one of the most prevalent genetic kidney disorders, which affects approximately 600,000 people in the United States;
Whereas National Polycystic Kidney Disease Awareness Month will help to foster an understanding of the impact polycystic kidney disease has on individuals and their families;
Whereas polycystic kidney disease is a progressive, genetic disorder of the kidneys that causes damage to the kidneys and the cardiovascular, endocrine, hepatic, and gastrointestinal organ systems;
Whereas polycystic kidney disease affects the health and finances of individuals, and equally affects individuals of all ages, races, ethnicities, and sexes;
Whereas, of the individuals diagnosed with polycystic kidney disease, approximately 10 percent have no family history of the disease, with the disease developing as a spontaneous mutation;
Whereas there are very few treatments and no cure for polycystic kidney disease, which is 1 of the 4 leading causes of kidney failure in the United States;
Whereas almost 50 percent of individuals with polycystic kidney disease experience kidney failure by age 60;
Whereas friends, loved ones, spouses, and caregivers of individuals with polycystic kidney disease can assist with the challenges created by polycystic kidney disease, including by helping such individuals maintain a healthy lifestyle and make regular visits to their health care providers;
Whereas the severity of the symptoms of polycystic kidney disease and limited public awareness of the disease may cause individuals to forgo regular visits to their physicians or avoid following the health recommendations of their doctors, which experts suggest could help prevent further complications should kidney failure occur;
Whereas individuals who have chronic, life-threatening diseases like polycystic kidney disease may experience depression; and
Whereas the PKD Foundation and its more than 35,000 patient and family advocates around the United States are dedicated to—
(1)
conducting research to find treatments and a cure for polycystic kidney disease;
(2)
fostering public awareness and understanding of polycystic kidney disease;
(3)
educating individuals and their families about the disease to improve their treatment and care; and
(4)
providing support, including by sponsoring the annual  Walk for PKD , to raise funds for polycystic kidney disease research, education, advocacy, and awareness: Now, therefore, be it
That the House of Representatives—
(1)
expresses support for the designation of  National Polycystic Kidney Disease Awareness Month ;
(2)
supports the goals and ideals of National Polycystic Kidney Disease Awareness Month to raise public awareness and understanding of polycystic kidney disease;
(3)
recognizes the need for additional research to find a cure for polycystic kidney disease; and
(4)
encourages all people in the United States and interested groups to support National Polycystic Kidney Awareness Month through appropriate ceremonies and activities to promote public awareness of polycystic kidney disease and to foster an understanding of the impact of the disease on individuals and their families.